FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Sunday

 

'My GP thought I'd pulled something at the gym' - concern raised about MS being misdiagnosed







































Claire Conlon, 29-year-old teacher from Glasgow, who had symptoms for three years before MS was diagnosed

A survey by the MS Society found 81 per cent of sufferers had been given different explanations for their symptoms - including depression and stress - before MS was identified.
Read more »

 

The case for medical marijuana for MS and other neurological diseases grows stronger








































Compassionate Care Center of New York (CCCNY), based in Newark, Wayne County, is applying to become one of five registered commercial suppliers that will be licensed in New York State to grow medical marijuana.
Read more »

Labels:


 

Multiple Sclerosis, Bladder Problems and Botox




























Image source: WIKIPEDIA


At least 80 percent of people with multiple sclerosis experience bladder problems, and treatment can be a challenge. One of the treatment options is onabotulinumtoxin A, also known as Botox.
Read more »

 

Multidisciplinary Team Approach Improves Multiple Sclerosis Relapse Care























Successful relapse management of multiple sclerosis (MS) requires a multidisciplinary team that is involved during the multiple stages of patient care, according to a presentation at the Consortium of Multiple Sclerosis Centers Annual Meeting.
Read more »

 

Human immunoglobulin G suppresses the production of matrix metalloproteinase-9 in peripheral blood mononuclear cells of patients with multiple sclerosis: STUDY


























Image source: JAGUARGENERATION.DE

Read more »

Labels:


Saturday

 

Jack Osbourne and Teva Launch Enhanced You Don’t Know Jack About MS® Website Featuring New Multimedia Content
































Multiple Sclerosis Patient Jack Osbourne Unveils New Resources to Empower Others with Multiple Sclerosis to Take a More Active Role in Managing Disease
Read more »

 

Anti-Lingo-1 (Biogen) – A New MS Therapy?

Image source: GADAPER

I have had my eye on a new medication/therapy being worked on by Biogen Idec (the makers of Tysabri, Avonex, Rituxan, Tecfidera, and Fampyra) that is currently being called Anti-Lingo-1. This medication caught my attention because it’s goal is to remyelinate (rebuild the protective layer of fat called myelin that insulates our nerves but are attacked by Multiple Sclerosis) nerves in the central nervous system (CNS). Pretty much all therapies so far have taken the approach of trying to prevent antibodies from destroying myelin in the first place but Anti-Lingo-1 aims to create new myelin to replenish the myelin that has been destroyed by MS. Not only should this help slow down or stop disease progression but this will hopefully even reverse some of the effects of MS, for example, it could heal the more “permanent” symptoms many of us with MS are stuck with.
Read more »

 

2015 Annual meeting of The Consortium Of MS Centers

2015 Annual Meeting   
Written by Jennifer Pichardo  

Read more »

 

FDA evaluates ZINBRYTA for MS treatment

























The U.S. Food and Drug Administration (FDA) has announced it will consider marketing approval of ZINBRYTA (daclizumab high-yield process), a potential treatment for relapsing forms of multiple sclerosis (MS). Biogen and AbbVie, who are jointly developing the therapy, have filed a Biologics License Application (BLA) with the FDA in hopes of winning approval.
Read more »

 

Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators

Friday

 

Protecting women from MS
























An innocent mistake made by a graduate student in a Northwestern Medicine lab (she accidentally used male mice instead of female mice during an experiment) has led scientists to a novel discovery that offers new insight into why women are more likely than men to develop autoimmune diseases such as multiple sclerosis (MS).
Read more »

 

New MS treatment could be too pricey



























A multiple sclerosis patient is seen with her new leg brace. (FILE PHOTO, POSTMEDIA)

A new multiple sclerosis treatment capable of halting the disease’s advancement for 10 years is being reviewed by government to determine if it’ll receive B.C. PharmaCare coverage.
Read more »

Labels:


 

I-Carnitine not effective for depression and chronic fatigue in MS and Neuromyelitis Optica



























A new study confirmed that depression and chronic fatigue often occur in multiple sclerosis (MS); and in a related condition known as neuromyelitis optica (NMO). NMO is similar to MS because myelin–the fatty substance that insulates nerve cells and helps them to communicate–is also lost. In NMO the myelin deteriorates mostly in the optic nerve, which can lead to blindness, and in the spinal cord. In MS myelin can be lost throughout the nervous system.
Read more »

Labels: ,


 

Study Shows MS Patients Are Living Longer Lives But Still 7.5 Years Shorter Than Others: STUDY














































People suffering from multiple sclerosis or MS may be living longer than before, but when compared to those who do not suffer from the ailment, their life expectancy is shorter.
Read more »

Labels:


 

Intravenous immunoglobulin may reduce relapse frequency in neuromyelitis optica: STUDY














































Image source: FINEARTAMERICA
Read more »

Labels:


Thursday

 

Staying positive, fighting MS





























Kristen Edwards, 37, with her daughter Paige Hollett, 4, at the 2015 Mandarin Multiple Sclerosis Walk in Kingston, Ont. on Sunday May 24, 2015. Edwards was diagnosed with MS at 31 and is just taking it one day at a time. Steph Crosier/Kingston Whig-Standard/Postmedia Network

Kristen Edwards is living life one day at a time.
Read more »

Labels:


 

Brain implant that moves robot arm could someday help MS patients with paralysis




































A new robotic device could help people with all types of paralysis, including patients with multiple sclerosis.
Read more »

 

What happens when multiple sclerosis patients stop taking their medication?






















This year the International Multiple Sclerosis Awareness Day takes place at the 27th of May; © panthermedia.net/semmickphoto

New research led by NYU Langone Medical Center examines what happens when a patient with multiple sclerosis (MS) who is clinically stable stops taking their medication. The international, multi-site study found almost 40 percent of patients had some disease activity return when they stopped taking their meds.
Read more »

Labels:


 

80% people with multiple sclerosis are misdiagnosed, study




















A leading charity in the UK has warned that about 80 per cent of the people suffering from multiple sclerosis are misdiagnosed by the doctors in the country.
Read more »

Labels:


 

Autologous hematopoietic stem cell transplantation in pediatric multiple sclerosis: Long-time follow-up: STUDY

















Image source: SCLERODERMANEWS
Read more »

Labels: , ,


Wednesday

 

New Compound Tested in Lab Shows Promise for Progressive Multiple Sclerosis

























Exploratory research conducted at Virginia Commonwealth University and the University of Illinois at Chicago may translate into a new therapeutic agent to treat progressive multiple sclerosis. Researchers in the laboratories of Dr. Jefferey L. Dupree and Dr. Douglas L. Feinstein tested a new compound in mice with induced multiple sclerosis and found that the compound reduced neurodegeneration and helped improve symptoms.
Read more »

Labels:


 

Amarantus Releases Preliminary Data From Blood-Based MS Diagnostic

























Amarantus BioScience has released preliminary data from a blood test for multiple sclerosis (MS) called the MSPrecise diagnostic. The company believes that the test could lead to more accurate diagnoses of MS early in the disease’s progression.
Read more »

 

Genzyme to collaborate with Ablynx on MS research project
























GHENT, Belgium, May 18, 2015 (GLOBE NEWSWIRE) -- Ablynx[Euronext Brussels: ABLX; OTC: ABYLY] today announced that it has entered into an exclusive research collaboration with Genzyme, a Sanofi company, to investigate Nanobodies® against a target that plays an important role in multiple sclerosis (MS) and specifically aligns with Genzyme's early-stage MS research programs involving neuroprotection and CNS repair.
Read more »

 

New genetic variant as predictor of patients' response to MS treatment























A team led by researchers at San Raffaele Scientific Institute in Italy and Brigham and Women’s Hospital in Boston, Massachusetts recently revealed a new genetic variant linked to multiple sclerosis (MS). The study is entitled “A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity” and is published in the journal Annals of Neurology.
Read more »

 

Toxoplasma gondii seropositivity is negatively associated with Multiple Sclerosis: STUDY





















Image source: NATIONALGEOGRAPHIC
Read more »

Labels:


Tuesday

 

Multiple Sclerosis Motivated Rutgers Nursing Student to Become an Advocate for Others






















Photo: Lindsay Benson Garrett
Transitioning to become a nurse practitioner, Stephanie Butler developed her skills as a writer and advocate for MS patients. Her blog, Justkeepsmyelin.com, was cited by Healthline.com as one of the "Best Health" blogs of 2014.

It was to be Stephanie Butler’s most exciting day as a student nurse. But while donning her scrubs three years ago and prepping to administer anesthesia to a patient for the first time, she sensed numbness in her limbs and then lost all feeling below the waist.
Read more »

Labels:


 

MS patient runs for first time in 20 years, thanks to special treadmill: VIDEO

























Bonnie Iglesias, of Hillsboro, after her workout at Tuality HealthPlace. (Luke Hammill / The Oregonian)

It had been 20 years since Bonnie Iglesias went for a run.
Read more »

Labels: ,


 

Multiple Sclerosis Booklets Essential to Understanding New Medications











MSology (www.msology.com) is proud to announce the launch of its MS Essentials series, a collection of free publications available for download by people affected by multiple sclerosis (MS). The first three booklets explain the oral medications - Aubagio (teriflunomide), Gilenya (fingolimod), and Tecfidera (dimethyl fumarate) - that are now used to treat MS.
Read more »

 

Multiple Sclerosis Patients Stressed Out By Soaring Drug Costs























American medicine is heading into new terrain, a place where a year's supply of drugs can come with a price tag that exceeds what an average family earns.
Read more »

 

Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis – an observational study: STUDY

Monday

 

Researchers find that blocking MCAM molecule could slow progression of multiple sclerosis






















Research Centre of the University of Montreal
Image source: MSDL

A drug that could halt the progression of multiple sclerosis may soon be developed thanks to a discovery by a team at the CHUM Research Centre and the University of Montreal. The researchers have identified a molecule called MCAM, and they have shown that blocking this molecule could delay the onset of the disease and significantly slow its progression. These encouraging results from in vitro tests in humans and in vivo tests in mice were published today in the Annals of Neurology. "We believe we have identified the first therapy that will impact the quality of life of people with multiple sclerosis by significantly reducing the disability and the disease's progression," said Dr. Alexandre Prat, lead author of the study, researcher at the CRCHUM, and professor in the Department of Neurosciences at the University of Montreal.
Read more »

 

Yale and MIT Researchers Discover a Key Immune Difference in Multiple Sclerosis Patients



























A new study recently published in the journal Science Translational Medicine revealed a key difference in immune T cells between multiple sclerosis (MS) patients and healthy individuals. The study is entitled “Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis” and was led by researchers at Yale School of Medicine, Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology (MIT) and The Broad Institute of MIT and Harvard.
Read more »

 

AIMS Helps To Improve The Care Of Multiple Sclerosis In Women





























Image source: DRPREM

Let us tenderly and kindly cherish, therefore, the means of knowledge. Let us dare to read, think, speak and write.” ~John Adams

We’ve always known that more women than men are diagnosed with Multiple Sclerosis. According to new data reported on the website Advances in Multiple Sclerosis (AIMS), women are diagnosed three times more than men. So AIMS is, well, taking AIM to address this issue by providing a place for women to go to learn as much about their disease as possible.
Read more »

 

Undergraduate studies class donates to six nonprofits


























Rather than learn how to make money, students in sociology professor Pamela Paxton’s undergraduate studies class learned how to give theirs away.
Read more »

 

Neuromuscular taping versus sham therapy on muscular strength and motor performance in multiple sclerosis patients: STUDY





























Image source: PRICEMINISTERS



Read more »

Labels:


Sunday

 

Multiple sclerosis: Scientists ID cause of movement, balance problems





























Image source: SNOWBRAINS


New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty "brake" within immune cells, a brake that should be controlling the inflammation. This points to a potential target for developing new therapies to treat multiple sclerosis and could have important implications for other autoimmune diseases, such as the colon disease colitis and the chronic skin condition atopic dermatitis.
Read more »

Labels:


 

Five Women in the MS Community Help Me Feel #strongerthanMS: Who Helps You?




















Did you ever hear the question, “If you could have anyone sit at your table, alive or dead, who would you choose?” When asked this question I’d usually answer with a variation of people like Eleanor Roosevelt, Cary Grant, Joan of Arc, Abraham Lincoln, Golda Meir, Mother Teresa, Albert Einstein and Frank Sinatra.
Read more »

Labels:


 

Multiple sclerosis patients, doctors assess costs vs. benefits of experimental treatment























Trina Cooper

How far would you go for a possible cure to an incurable disease? How much money would you spend? How great a risk could you accept?
Read more »

 

Just Get Over It: The Fallacy of Closure

















Just get over it. It’s in the past, forget about it.

These are shaming, dismissive words, as advocate/songwriter Michael Skinner so eloquently points out and explores in his support work. We’ve all heard some version of this about a tragedy, a drama, an injustice. Like a scolding older sibling, we’ve even taken ourselves aside and told our infantile alter-egos to buck up. It’s a pop psychology anthem for how to cope with the ever-accumulating baggage we all collect if we live long enough.
Read more »

 

Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial: STUDY
































Image source: PRWEB


Read more »

Labels: ,


Saturday

 

5 Pieces of Advice for the Newly Diagnosed















I’m a few years into the MS game now, and I often find myself exchanging e-mails with people who have just been diagnosed. I never hesitate to extend a helping hand and a few words of advice, especially since I was on the receiving end not too long ago. I’ll never forget the people (some of whom were complete strangers) who were kind enough to talk to me, and help me through that initial period after diagnosis. My hope is that I can pay it forward as much as possible.
Read more »

Labels:


 

Health Beat: Massage for MS: VIDEO






















Shavonne Thurman was in her 20s when numbness in her abdomen and double vision sent her to the doctor. She was diagnosed with multiple sclerosis, which has slowly progressed.
Read more »

Labels:


 

Singer Releases Song About MS Recovery After Receiving Stem Cell Therapy





















Kristen King


Singer Kristen King began to experience fatigue, muscle weakness and later paralysis in some parts of the body in 2013, and it came as a shock when she was diagnosed with multiple sclerosis (MS). After struggling to deal with the unfortunate news and her new reality, the singer has now launched a new song entitled “Impervious” about her battle with the disease, which led her to undergo a stem cell treatment.
Read more »

Labels:


 

Yoga for Multiple Sclerosis Patients

























There are 400,000 cases of Multiple Sclerosis in the U.S. but a doctor and a yoga instructor in Great Falls are trying to help those with the disease in an alternative way a special yoga class for those suffering from M.S.
Read more »

 

Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with Copaxone (glatiramer acetate)































Image source: MYELITETMOI
Read more »

Labels: ,


Friday

 

Hawaii committee passes medical marijuana dispensries bill






















Teri Heede, 60, talks about a bill to set up medical marijuana dispensaries on Monday, May 4, 2015 in Honolulu. Medical marijuana was legalized in Hawaii nearly 15 years ago, but patients like Heede, who has multiple sclerosis, have been left to grow the drug on their own or buy it on the black market. (AP Photo/Cathy Bussewitz)
Story Source: The above story is based on materials provided by WASHINGTONTIMES
Note: Materials may be edited for content and length
Click here to see more

Labels:


 

Two existing drugs may potentially become new drug target for multiple sclerosis































Image Source: UCDENVER

Two drugs already on the market -- an antifungal and a steroid -- may potentially take on new roles as treatments for multiple sclerosis. According to a study published in Nature today, researchers discovered that these drugs may activate stem cells in the brain to stimulate myelin producing cells and repair white matter, which is damaged in multiple sclerosis. The study was partially funded by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.
Read more »

Labels:


 

Multiple Sclerosis, Crohn’s Drug Used in HIV Targeted Therapy





























Multiple sclerosis (MS) and Crohn’s disease drug Tysabri (Biogen Idec Inc.) can be used to fight against human immunodeficiency virus (HIV), according to research published in PLOS Pathogens.
Read more »

 

Your Healthy Family: Living with MS: VIDEO


Rob Harasimowicz

News 5 sat down with a local man living with Multiple Sclerosis who's now an ambassador for the MS society.
Read more »

Labels:


 

Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis – an observational study: STUDY


Go to Newer News Go to Older News